In this study, we discovered that enhancing Nav1.9 activity may recover the pain deficit in CIP caused by loss-of-function of Nav1.7, which was revealed by the intensive study of HpTx1 as a probe. This evidence concerns the gene SCN9A and hereditary sensory and autonomic neuropathy.